Liver mass evaluation

	Lung Mass Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Causes
Differentiating Lung Mass from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Diagnosis
Diagnostic Study of Choice
Evaluation of Lung Mass
Imaging of Lung Mass
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Liver mass evaluation On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Liver mass evaluation All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Liver mass evaluation
CDC on Liver mass evaluation
Liver mass evaluation in the news
Blogs on Liver mass evaluation
Directions to Hospitals Treating bone or soft tissue mass
Risk calculators and risk factors for Liver mass evaluation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

A hallmark feature in the evaluation of liver mass is the malignancy assessment. The evaluation approach of liver mass will mainly depend in the initial morphological evaluation of the mass (size, margins, contours, imaging pattern, and growth). Other characteristics, such as: location, clinical features, and distribution may be helpful for the therapeutical management, surveillance, and follow-up of liver mass. Lung mass can be divided into 2 categories: benign liver mass and malignant liver mass. Based upon these categories, complementary diagnostic studies and management, include: PET/CT scan, CT scan, non-surgical biopsy, and surgical resection.